Study on the Discrimination of Bovis Calculus and Its Substitutes in Clinical Medication for Acute and Severe Illnesses Guided by Precise Supervision

Shi Yan, Jing Wenguang, Cheng Xianlong, Wei Feng, Xiong Jing*

Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (7) : 775-782.

PDF(1640 KB)
PDF(1640 KB)
Chinese Pharmaceutical Affairs ›› 2024, Vol. 38 ›› Issue (7) : 775-782. DOI: 10.16153/j.1002-7777.2024.07.008
Regulatory Technology

Study on the Discrimination of Bovis Calculus and Its Substitutes in Clinical Medication for Acute and Severe Illnesses Guided by Precise Supervision

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 38(7): 775-782 https://doi.org/10.16153/j.1002-7777.2024.07.008

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1640 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉